港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医药外包概念

1,793.042

+20.8101.17%

涨家数：4

跌家数：4

平家数：- -

市盈率：- -

高：1,835.570

开：1,770.415

低：1,747.549

收：1,772.232

数据加载中...

港股异动 | 来凯医药-B(02105)涨超8% 自研新药LAE120获美国FDA临床试验批准

方达控股盘中异动股价大跌7.32%

药明康德盘中异动股价大涨3.03%

昭衍新药盘中异动股价大涨5.75%报13.980港元

药明生物(02269)出现大手卖出31.45万股，成交价$22.45，涉资706.052万

阿斯达克财经

【百利天恒：BL-B01D1（EGFR×HER3 双抗 ADC）联合奥希替尼用于一线 EGFR 突变型局部晚期或转移性非小细胞肺癌 III 期临床试验完成首例受试者入组】金融界3月2日消息，百利天恒自主研发的创新生物药注射用 BL-B01D1（EGFR×HER3 双抗 ADC）联合奥希替尼用于一线 EGFR 突变型局部晚期或转移性非小细胞肺癌的 III 期临床试验已于近日完成首例受试者入组。BL-B01D1 是全球独家处于 III 期注册临床试验阶段的可同时靶向 EGFR 和 HER3 的双抗 ADC 药物。截至目前，BL-B01D1 正在中国和美国进行约 30 项针对多种肿瘤类型的临床试验，除本次新入组的临床试验外，其在肺癌、乳腺癌、鼻咽癌、食管鳞癌等 7 项国内 III 期注册临床试验也处于受试者入组阶段。药品需完成临床试验并通过审评审批方可上市销售，且医药产品具有高科技、高风险等特点，容易受到不确定性因素影响。

康希诺业绩出炉，营收大增137%，股价不涨反跌？

昆药集团(600422.SH)：天麻素注射液临床试验获批准

泰格医药02月28日遭主力抛售483万元

昭衍新药02月28日遭主力抛售492万元

维亚生物(01873)股价下跌9.091%，现价港币$1.3

阿斯达克财经

泰格医药盘中异动下午盘急速跳水5.09%报34.500港元

维亚生物盘中异动下午盘快速跳水5.59%

金斯瑞生物科技盘中异动下午盘快速跳水5.13%

药明生物(02269)下跌5.07%，报22.45元/股

药明生物盘中异动股价大跌5.07%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1576/news?page=7"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"医药外包概念","latestPrice":1793.0419,"timestamp":1741334919514,"preClose":1772.232,"halted":0,"volume":105965997,"delay":0,"changeRate":0.011742,"change":20.809814,"pbRate":2.65369,"amount":2334342230,"amplitude":0.049667,"prevYearClose":1395.7731,"fiveDayClose":1699.456,"twentyDayClose":1588.191,"turnoverRate":0.008873,"marketCap":381645564416,"floatMarketCap":165840598400,"peRate":33.079805},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":1835.5696,"amplitude":0.049667,"preClose":1772.232,"low":1747.5487,"pbRate":"2.65369","latestPrice":1793.0419,"volume":105965997,"delay":0,"open":1770.415,"prevYearClose":1395.7731,"prevWeekClose":1699.456,"prevMonthClose":1699.456,"prevQuarterClose":1395.773,"fiveDayClose":1699.456,"twentyDayClose":1588.191,"sixtyDayClose":1337.64,"secType":"PLATE","market":"HK","turnoverRate":0.008873,"peRate":33.079805,"marketCap":381645564416,"floatMarketCap":165840598400,"timestamp":1741334919514,"nameCN":"医药外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":4,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:16,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516575333","title":"港股异动 | 来凯医药-B(02105)涨超8% 自研新药LAE120获美国FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2516575333","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516575333?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 11:29","pubTimestamp":1740972568,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，来凯医药-B涨超8%，截至发稿，涨8.63%，报13.6港元，成交额8370.23万港元。消息面上，来凯医药今早宣布，美国食品药品监督管理局已批准其自主研发的LAE120，一种强效、高选择性USP1抑制剂的新药临床试验申请，用于治疗晚期实体瘤患者。公司表示正积极开展外部合作以加快LAE120临床开发进展。除LAE120，来凯自主研发的另一款抗肿瘤潜在药物LAE118也进入了IND支持性研究阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK1576","BK1161","BK1141","BK1583","03347"],"gpt_icon":0},{"id":"2516827578","title":"方达控股盘中异动 股价大跌7.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516827578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516827578?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 10:43","pubTimestamp":1740969816,"startTime":"0","endTime":"0","summary":"2025年03月03日早盘10时43分，方达控股股票出现波动，股价急速下跌7.32%。截至发稿，该股报1.140港元/股，成交量62.6万股，换手率0.03%，振幅8.13%。资金方面，该股资金流入12.184万港元，流出58.574万港元。机构评级方面，在所有1家参与评级的机构中，100%的券商给予卖出建议，无券商给予买入、持有建议。方达控股股票所在的生物技术行业中，整体涨幅为0.14%。北美和欧洲部门包括美国、加拿大和欧洲。中国部门包括中国。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303104336989943e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303104336989943e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1583","01521","BK1576"],"gpt_icon":0},{"id":"2516752201","title":"药明康德盘中异动 股价大涨3.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516752201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516752201?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 09:52","pubTimestamp":1740966740,"startTime":"0","endTime":"0","summary":"2025年03月03日早盘09时52分，药明康德股票出现异动，股价快速拉升3.03%。截至发稿，该股报61.150港元/股，成交量103.643万股，换手率0.27%，振幅2.95%。资金方面，该股资金流入3389.47万港元，流出1549.52万港元。药明康德股票所在的生物技术行业中，整体跌幅为1.33%。其相关个股中，昭衍新药、科济药业-B、云顶新耀-B涨幅较大，振幅较大的相关个股有创胜集团-B、永泰生物-B、百奥赛图-B，振幅分别为20.41%、11.31%、10.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030309522098993174&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030309522098993174&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU0052750758.USD","LU1046422090.SGD","LU0320764599.SGD","LU2125910500.SGD","LU2045819591.USD","BK1576","BK1583","LU2242644610.SGD","02359","LU0708995583.HKD"],"gpt_icon":0},{"id":"2516524796","title":"昭衍新药盘中异动 股价大涨5.75%报13.980港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516524796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516524796?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 09:44","pubTimestamp":1740966258,"startTime":"0","endTime":"0","summary":"2025年03月03日早盘09时44分，昭衍新药股票出现波动，股价急速上涨5.75%。截至发稿，该股报13.980港元/股，成交量60.84万股，换手率0.51%，振幅4.99%。资金方面，该股资金流入457.631万港元，流出235.721万港元。昭衍新药股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，昭衍新药、科济药业-B、圣诺医药-B涨幅较大，振幅较大的相关个股有创胜集团-B、永泰生物-B、腾盛博药-B，振幅分别为20.41%、11.31%、8.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303094418abe537b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303094418abe537b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2516727521","title":"药明生物(02269)出现大手卖出31.45万股，成交价$22.45，涉资706.052万","url":"https://stock-news.laohu8.com/highlight/detail?id=2516727521","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516727521?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 09:20","pubTimestamp":1740964800,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在上午09:20出现大手卖出，成交量为31.45万，成交价为港币$22.45，涉资706.052万。至目前为止，股价无升跌，今日最高价为$22.45，而最低价为$22.45，总成交量为198.385万股，总成交金额港币$4.449千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT25030358/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1794554557.SGD","LU0043850808.USD","LU0348825331.USD","LU1880383366.USD","LU1242518857.USD","LU0051755006.USD","BK1589","LU0516423091.SGD","LU0140636845.USD","LU0572944931.SGD","LU0417516902.SGD","LU0708995583.HKD","LU0516422952.EUR","LU0359201612.USD","LU1242518931.SGD","LU1720050803.USD","LU0039217434.USD","LU0417516738.SGD","LU0823426308.USD","BK1141","SG9999002463.SGD","LU0856984785.SGD","LU0327786744.USD","LU0348735423.USD","LU0326950275.SGD","LU0823426480.USD","LU0516423174.USD","LU0588546209.SGD","IE00B0JY6N72.USD","LU0979878070.USD","LU0320764599.SGD","LU0052750758.USD","LU0819121731.USD","LU1688375341.USD","02269","LU2039709279.SGD","LU0359202008.SGD","SG9999002562.SGD","LU0307460666.USD","BK1610","LU0516422366.SGD","LU0456827905.SGD","LU0516422440.USD","BK1576","LU0456846285.SGD","BK1521","LU0181495838.USD"],"gpt_icon":0},{"id":"2516364590","title":"【百利天恒：BL-B01D1（EGFR×HER3 双抗 ADC）联合奥希替尼用于一线 EGFR 突变型局部晚期或转移性非小细胞肺癌 III 期临床试验完成首例受试者入组】金融界3月2日消息，百利天恒自主研发的创新生物药注射用 BL-B01D1（EGFR×HER3 双抗 ADC）联合奥希替尼用于一线 EGFR 突变型局部晚期或转移性非小细胞肺癌的 III 期临床试验已于近日完成首例受试者入组。BL-B01D1 是全球独家处于 III 期注册临床试验阶段的可同时靶向 EGFR 和 HER3 的双抗 ADC 药物。截至目前，BL-B01D1 正在中国和美国进行约 30 项针对多种肿瘤类型的临床试验，除本次新入组的临床试验外，其在肺癌、乳腺癌、鼻咽癌、食管鳞癌等 7 项国内 III 期注册临床试验也处于受试者入组阶段。药品需完成临床试验并通过审评审批方可上市销售，且医药产品具有高科技、高风险等特点，容易受到不确定性因素影响。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516364590","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516364590?lang=zh_cn&edition=fundamental","pubTime":"2025-03-02 15:34","pubTimestamp":1740900843,"startTime":"0","endTime":"0","summary":"金融界3月2日消息，百利天恒自主研发的创新生物药注射用 BL-B01D1 联合奥希替尼用于一线 EGFR 突变型局部晚期或转移性非小细胞肺癌的 III 期临床试验已于近日完成首例受试者入组。BL-B01D1 是全球独家处于 III 期注册临床试验阶段的可同时靶向 EGFR 和 HER3 的双抗 ADC 药物。截至目前，BL-B01D1 正在中国和美国进行约 30 项针对多种肿瘤类型的临床试验，除本次新入组的临床试验外，其在肺癌、乳腺癌、鼻咽癌、食管鳞癌等 7 项国内 III 期注册临床试验也处于受试者入组阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/02153448475153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","LU1815336091.USD","BK1141","BK4023","09939","III","159938","ADC","BL","LU0757428866.USD","BK1161","BK1574","BK4080","BK4134","03347","BK1583","159839","BK0239","BK1576","688506","BK4231"],"gpt_icon":0},{"id":"2516372983","title":"康希诺业绩出炉，营收大增137%，股价不涨反跌？","url":"https://stock-news.laohu8.com/highlight/detail?id=2516372983","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516372983?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 19:26","pubTimestamp":1740741978,"startTime":"0","endTime":"0","summary":"昨日，港股的疫苗企业康希诺生物（06185.HK）发布2024年度业绩快报，表现可圈可点。根据其A股三季报，康希","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202502_1/05a175fc-813c-4bc3-95e8-bed2a53c298e.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202502_1/05a175fc-813c-4bc3-95e8-bed2a53c298e.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/67c19d5a23082975a38f607b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["LU0856984785.SGD","LU0052750758.USD","LU0051755006.USD","LU1242518857.USD","LU0572944931.SGD","LU0456827905.SGD","01877","LU0516423091.SGD","LU0979878070.USD","LU0348735423.USD","BK1161","LU0181495838.USD","LU2039709279.SGD","LU0516423174.USD","LU0516422952.EUR","BK1583","06185","LU0819121731.USD","BK1589","LU0516422366.SGD","BK1574","BK1576","LU0359202008.SGD","BK1141","BK1515","LU1880383366.USD","LU0307460666.USD","BK1610","SG9999002562.SGD","SG9999002463.SGD","LU0708995583.HKD","BK1521","BK1191","LU0359201612.USD","LU0456846285.SGD","LU0588546209.SGD","LU1688375341.USD","LU0823426480.USD","LU0043850808.USD","LU0327786744.USD","LU0348825331.USD","LU0320764599.SGD","LU0326950275.SGD","LU0417516738.SGD","LU0516422440.USD","LU0140636845.USD","LU0823426308.USD","LU1242518931.SGD","LU1794554557.SGD"],"gpt_icon":1},{"id":"2514435243","title":"昆药集团(600422.SH)：天麻素注射液临床试验获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2514435243","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514435243?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 17:15","pubTimestamp":1740734140,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昆药集团(600422.SH)公告，公司近日收到国家药品监督管理局签发的天麻素注射液按照化学药品2.4类新药受理的《药物临床试验批准通知书》，同意该新药开展相关临床试验研究，该新药适应症为：预防心脏外科术后谵妄。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","600422","BK1576","BK1583","BK0239","03347","BK0188","BK0028","BK0060"],"gpt_icon":0},{"id":"2514348825","title":"泰格医药02月28日遭主力抛售483万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514348825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514348825?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 16:17","pubTimestamp":1740730640,"startTime":"0","endTime":"0","summary":"02月28日, 泰格医药股价跌6.88%，报收33.85元，成交金额1.78亿元，换手率4.16%，振幅9.90%，量比0.71。泰格医药今日主力资金净流出483万元，上一交易日主力净流出37万元。该股近5个交易日下跌13.08%，主力资金累计净流出2704万元；近20日主力资金累计净流入1251万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228165711a2579d8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228165711a2579d8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","03347","BK1583"],"gpt_icon":0},{"id":"2514348385","title":"昭衍新药02月28日遭主力抛售492万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514348385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514348385?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 16:16","pubTimestamp":1740730597,"startTime":"0","endTime":"0","summary":"02月28日, 昭衍新药股价跌15.04%，报收13.22元，成交金额8936万元，换手率5.41%，振幅17.74%，量比0.86。昭衍新药今日主力资金净流出492万元，上一交易日主力净流出145万元。该股近5个交易日下跌2.81%，主力资金累计净流出88万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入2110万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228165606a2579d0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228165606a2579d0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","06127","BK1576"],"gpt_icon":0},{"id":"2514397299","title":"维亚生物(01873)股价下跌9.091%，现价港币$1.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2514397299","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514397299?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 14:25","pubTimestamp":1740723900,"startTime":"0","endTime":"0","summary":"[下跌股]维亚生物(01873) 股价在下午02:25比前收市价下跌9.091%，现股价为港币$1.3。至目前为止，今日最高价为$1.43，而最低价为$1.3。总成交量为320.2万股，总成交金额为港币$438.336万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2502286799/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01873","BK1576","BK1141"],"gpt_icon":0},{"id":"2514391159","title":"泰格医药盘中异动 下午盘急速跳水5.09%报34.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514391159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514391159?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 13:38","pubTimestamp":1740721101,"startTime":"0","endTime":"0","summary":"2025年02月28日下午盘13时38分，泰格医药股票出现波动，股价快速跳水5.09%。截至发稿，该股报34.500港元/股，成交量251.09万股，换手率2.04%，振幅6.74%。资金方面，该股资金流入3535.17万港元，流出4007.46万港元。最近的财报数据显示，该股实现营业收入56.20亿港元，净利润9.02亿港元，每股收益1.04港元，毛利21.85亿港元，市盈率13.34倍。泰格医药股票所在的生物技术行业中，整体跌幅为0.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281338219895dcd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281338219895dcd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","BK1583","03347"],"gpt_icon":0},{"id":"2514539417","title":"维亚生物盘中异动 下午盘快速跳水5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514539417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514539417?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 13:20","pubTimestamp":1740720002,"startTime":"0","endTime":"0","summary":"2025年02月28日下午盘13时20分，维亚生物股票出现波动，股价快速下跌5.59%。截至发稿，该股报1.350港元/股，成交量247.45万股，换手率0.12%，振幅5.59%。资金方面，该股资金流入135.189万港元，流出194.393万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。维亚生物股票所在的生物技术行业中，整体跌幅为0.05%。维亚生物公司简介：维亚生物科技控股集团是一家投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228132002a2575429&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228132002a2575429&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01873","BK1141","BK1576"],"gpt_icon":0},{"id":"2514399941","title":"金斯瑞生物科技盘中异动 下午盘快速跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514399941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514399941?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 13:11","pubTimestamp":1740719483,"startTime":"0","endTime":"0","summary":"2025年02月28日下午盘13时11分，金斯瑞生物科技股票出现波动，股价急速跳水5.13%。截至发稿，该股报12.580港元/股，成交量1180.31万股，换手率0.55%，振幅5.73%。金斯瑞生物科技股票所在的生物技术行业中，整体涨幅为0.10%。金斯瑞生物科技公司简介：金斯瑞生物科技股份有限公司是一家主要从事生物科学研究及相关业务的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228131123abe03ff3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228131123abe03ff3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000306685.HKD","BK1141","01548","HK0000306701.USD","HK0000320223.HKD","HK0000320264.USD","BK1583","BK1576"],"gpt_icon":0},{"id":"2514360108","title":"药明生物(02269)下跌5.07%，报22.45元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514360108","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514360108?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 11:20","pubTimestamp":1740712824,"startTime":"0","endTime":"0","summary":"2月28日，药明生物(02269)盘中下跌5.07%，截至11:20，报22.45元/股，成交6.66亿元。药明生物技术有限公司是全球领先的生物制剂服务供应商，提供全面、综合及高度定制的服务，包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额，已与全球20大制药公司中的12家建立合作关系。截至2024年中报，药明生物营业总收入85.74亿元、净利润14.99亿元。3月25日，药明生物将披露2024财年年报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/28112048448598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0052750758.USD","LU0708995583.HKD","LU0307460666.USD","LU0516422366.SGD","LU0417516902.SGD","SG9999002562.SGD","LU0516423174.USD","IE00B0JY6N72.USD","LU0181495838.USD","LU0039217434.USD","LU0516422440.USD","LU0856984785.SGD","LU1720050803.USD","BK1589","BK1576","LU0417516738.SGD","LU0979878070.USD","LU0819121731.USD","LU0823426308.USD","BK1610","LU1242518931.SGD","LU0348735423.USD","LU0326950275.SGD","BK1141","LU0588546209.SGD","BK1521","LU0043850808.USD","LU0140636845.USD","LU0327786744.USD","LU0348825331.USD","LU0320764599.SGD","LU0456827905.SGD","LU1242518857.USD","LU1880383366.USD","LU0359202008.SGD","SG9999002463.SGD","LU1794554557.SGD","LU0516423091.SGD","LU0051755006.USD","02269","LU0359201612.USD","LU0456846285.SGD","LU0516422952.EUR","LU0572944931.SGD","LU0823426480.USD","LU2039709279.SGD","LU1688375341.USD"],"gpt_icon":0},{"id":"2514589360","title":"药明生物盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514589360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514589360?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 11:20","pubTimestamp":1740712822,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘11时20分，药明生物股票出现波动，股价快速跳水5.07%。截至发稿，该股报22.450港元/股，成交量2900.51万股，换手率0.71%，振幅5.07%。资金方面，该股资金流入2.45638亿港元，流出3.71824亿港元。药明生物股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，迈博药业-B、帝王国际投资、奥星生命科技涨幅较大，振幅较大的相关个股有帝王国际投资、科笛-B、昭衍新药，振幅分别为23.08%、16.33%、13.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281120229895bbd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281120229895bbd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417516902.SGD","LU1720050803.USD","LU0417516738.SGD","LU0572944931.SGD","LU0327786744.USD","LU0051755006.USD","02269","LU0052750758.USD","LU0823426480.USD","IE00B0JY6N72.USD","LU0140636845.USD","LU0348735423.USD","LU0516423174.USD","LU1688375341.USD","SG9999002562.SGD","BK1610","LU1242518931.SGD","SG9999002463.SGD","LU0823426308.USD","LU0708995583.HKD","LU1242518857.USD","BK1576","LU0348825331.USD","LU0359202008.SGD","LU0307460666.USD","LU0516422440.USD","LU0856984785.SGD","LU0039217434.USD","LU1880383366.USD","LU0326950275.SGD","LU0516422366.SGD","LU0359201612.USD","LU0043850808.USD","LU0516422952.EUR","BK1141","LU1794554557.SGD","LU0819121731.USD","LU0181495838.USD","LU0516423091.SGD","LU0588546209.SGD","LU0320764599.SGD","LU2039709279.SGD","BK1589","LU0456846285.SGD","LU0456827905.SGD","LU0979878070.USD","BK1521"],"gpt_icon":1}],"pageSize":16,"totalPage":14,"pageCount":7,"totalSize":210}]}}